Company news

COVID-19 has become a "global epidemic", and all countries are in urgent need of COVID-19 testing reagents. In order to effectively support the international community in tackling the global epidemic crisis,

Our company's "Novel Coronavirus Antibody Screening and Shunt Prevention and Control rapid detection system" has been approved by Xiamen Science and Technology Bureau.

Xiamen Wiz Biotech Co., Ltd. was listed and traded on the New Third Board on February 5, 2017. The stock name is Wiz Biotech (stock code 839355).

The 2016 annual Awards & Dinner party was held in Xiamen Mingshi Jindian Seafood Hotel.

Xiamen WIZ Biotech Co., LTD., founded in July 2013, is a high-tech company engaged in the research and development, production and sales of rapid diagnostic reagents and instruments.

In 2015, Xiamen Wiz Biotech Co., Ltd obtained high-tech enterprise certificate after the relevant government departments strict assessment. Wiz Biotech will take this opportunity to continuously carry out technological innovation and improve the technical level of the enterprise.

Wiz Biotech has obtained ISO9001 and ISO13485 certificates in Jan 5th, 2016, which shows that our enterprise has a perfect quality management system.

On September 18, 2015, Xiamen Wiz Biotech Co., Ltd. successfully held the third Mid-Autumn dinner party in Kanehi Seafood Restaurant.

In March 2013, Dr. Duan Xiaobo, director of research and development of Wiz Biotech, was selected as the fourth batch of high-level talents in Xiamen "Double Hundred Plan" A+ entrepreneurial and innovative talents.

In April 2015, the R&D team led by the project director Dr. Zhou Xiaoguang was successfully selected as the fourth batch of high-level innovation team introduced in Fujian province.